Ohcanbohtosat - Kim Sigaloff
- Čájehuvvo 1 - 20 / 33
- Sirdás čuovvovaš siidui
-
1
-
2
Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis Dahkki Ragna S. Boerma, Kim Sigaloff, Sulaimon Akanmu, Seth Inzaule, Michaël Boele van Hensbroek, Tobias F. Rinke de Wit, Job C. J. Calis
Almmustuhtton 2016Revisão -
3
Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala Dahkki Nicaise Ndembi, Raph L Hamers, Kim Sigaloff, Frederick Lyagoba, Brian Magambo, Bridget Nanteza, Christine Watera, Pontiano Kaleebu, Tobias F. Rinke de Wit
Almmustuhtton 2011Artigo -
4
Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis Dahkki T. Sonia Boender, Kim Sigaloff, James McMahon, Sasisopin Kiertiburanakul, Michael R. Jordan, Jhoney Barcarolo, Nathan Ford, Tobias F. Rinke de Wit, Silvia Bertagnolio
Almmustuhtton 2015Revisão -
5
Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis Dahkki Ragna S. Boerma, T. Sonia Boender, Anton P. Bussink, Job C. J. Calis, Silvia Bertagnolio, Tobias F. Rinke de Wit, Michaël Boele van Hensbroek, Kim Sigaloff
Almmustuhtton 2016Revisão -
6
-
7
Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children Dahkki Cissy Kityo, Ragna S. Boerma, Kim Sigaloff, Elizabeth Kaudha, Job C. J. Calis, Victor Musiime, Sheila N. Balinda, Rita Nakanjako, T. Sonia Boender, Peter Mugyenyi, Tobias F. Rinke de Wit
Almmustuhtton 2017Artigo -
8
HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes Dahkki Raph L Hamers, Hans L. Zaaijer, Carole L. Wallis, Margaret Siwale, Prudence Ive, Mariëtte E. Botes, Kim Sigaloff, Andy I. M. Hoepelman, Wendy Stevens, Tobias F. Rinke de Wit
Almmustuhtton 2013Artigo -
9
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa Dahkki David van de Vijver, Brooke E Nichols, Ume L. Abbas, Charles A. Boucher, Valentina Cambiano, Jeffrey W. Eaton, Robert Glaubius, Katrina Lythgoe, John W. Mellors, Andrew Phillips, Kim Sigaloff, Timothy B. Hallett
Almmustuhtton 2013Artigo -
10
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa Dahkki Kim Sigaloff, Raph L Hamers, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Prudence Ive, Mariëtte E. Botes, Kishor Mandaliya, Maureen Wellington, Akin Osibogun, Wendy Stevens, Michèle van Vugt, Tobias F. Rinke de Wit
Almmustuhtton 2011Artigo -
11
Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa Dahkki Kim Sigaloff, Raph L Hamers, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Prudence Ive, M. E. Botes, Kishor Mandaliya, Melanie Wellington, Akin Osibogun, Wendy Stevens, Michèle van Vugt, Tobias F. Rinke de Wit
Almmustuhtton 2012Artigo -
12
Global Differences in the Management of <i>Staphylococcus aureus</i> Bacteremia: No International Standard of Care Dahkki Annette C. Westgeest, David T.P. Buis, Kim Sigaloff, Felicia Ruffin, Leo G. Visser, Yunsong Yu, Emile F. Schippers, Merel M. C. Lambregts, Steven Y. C. Tong, Mark de Boer, Vance G. Fowler
Almmustuhtton 2023Artigo -
13
Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies Dahkki Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Prudence Ive, M. E. Botes, Melanie Wellington, Akin Osibogun, Wendy Stevens, Tobias F. Rinke de Wit, Rob Schuurman
Almmustuhtton 2012Artigo -
14
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa Dahkki T. Sonia Boender, Cissy Kityo, Ragna S. Boerma, Raph L Hamers, Pascale Ondoa, Maureen Wellington, Margaret Siwale, Immaculate Nankya, Elizabeth Kaudha, Sulaimon Akanmu, Mariëtte E. Botes, Kim Steegen, Job C. J. Calis, Tobias F. Rinke de Wit, Kim Sigaloff
Almmustuhtton 2016Artigo -
15
Multicentre analysis of second‐line antiretroviral treatment in HIV‐infected children: adolescents at high risk of failure Dahkki Ragna S. Boerma, Torsak Bunupuradah, Dorothy E. Dow, Joseph Fokam, Azar Kariminia, Dara A. Lehman, Cissy Kityo, Victor Musiime, Paul Palumbo, Annelot F. Schoffelen, Sophan Sam, Brian C. Zanoni, Tobias F. Rinke de Wit, Job C. J. Calis, Kim Sigaloff
Almmustuhtton 2017Artigo -
16
The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy Dahkki Roos Wijnakker, Maurits S. van Maaren, L. Bode, Maja Bulatović, Bart Hendriks, Masja Loogman, Suzanne P. M. Lutgens, Ananja Middel, Chris Nieuwhof, Eveline E. Roelofsen, Jan W. Schoones, Kim Sigaloff, A. B. Sprikkelman, Lieke M.M. de Vrankrijker, Mark de Boer
Almmustuhtton 2023Artigo -
17
Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa Dahkki T. Sonia Boender, Bernice M Hoenderboom, Kim Sigaloff, Raph L Hamers, Maureen Wellington, Tinei Shamu, Margaret Siwale, Eman E. F. Labib Maksimos, Immaculate Nankya, Cissy Kityo, Titilope A. Adeyemo, Sulaimon Akanmu, Kishor Mandaliya, Mariëtte E. Botes, Pascale Ondoa, Tobias F. Rinke de Wit
Almmustuhtton 2015Artigo -
18
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa Dahkki T. Sonia Boender, Raph L Hamers, Pascale Ondoa, Maureen Wellington, Cleophas Chimbetete, Margaret Siwale, Eman E. F. Labib Maksimos, Sheila N. Balinda, Cissy Kityo, Titilope A. Adeyemo, Sulaimon Akanmu, Kishor Mandaliya, Mariëtte E. Botes, Wendy Stevens, Tobias F. Rinke de Wit, Kim Sigaloff
Almmustuhtton 2016Artigo -
19
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa Dahkki Stefanie Kroeze, Pascale Ondoa, Cissy Kityo, Margaret Siwale, Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Marieke E. de Pundert, Kim Sigaloff, Peter Reiss, Ferdinand W.N.M. Wit, Tobias F. Rinke de Wit, Raph L Hamers
Almmustuhtton 2018Artigo -
20
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study Dahkki Andrew Phillips, Valentina Cambiano, Fumiyo Nakagawa, Paul Revill, Michael R. Jordan, Timothy B. Hallett, Meg Doherty, Andrea De Luca, Jens Lundgren, Mutsa Mhangara, Tsitsi Apollo, John W. Mellors, Brooke E Nichols, Urvi M. Parikh, Deenan Pillay, Tobias Rinke de Wit, Kim Sigaloff, Diane V. Havlir, Daniel R. Kuritzkes, Anton Pozniak, David van de Vijver, Marco Vitória, Mark A. Wainberg, Elliot Raizes, Silvia Bertagnolio, Andrew Phillips, Valentina Cambiano, Fumiyo Nakagawa, Paul Revill, Michael R. Jordan, Timothy B. Hallett, Meg Doherty, Andrea De Luca, Jens Lundgren, Mutsa Mhangara, Tsitsi Apollo, John W. Mellors, Brooke E Nichols, Urvi M. Parikh, Deenan Pillay, Tobias Rinke de Wit, Kim Sigaloff, Diane V. Havlir, Daniel R. Kuritzkes, Anton Pozniak, David van de Vijver, Marco Vitória, Mark A. Wainberg, Elliot Raizes, Silvia Bertagnolio
Almmustuhtton 2017Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Human immunodeficiency virus (HIV)
Virology
Biology
Viral load
Antiretroviral therapy
Immunology
Microbiology
Drug resistance
Cohort
HIV drug resistance
Intensive care medicine
Cohort study
Coronavirus disease 2019 (COVID-19)
Disease
Drug
Infectious disease (medical specialty)
Pediatrics
Pharmacology
Confidence interval
Engineering
Ecology
Environmental health
Genetics
Immune system
Pathology
Prospective cohort study
Resistance (ecology)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)